Raxar

---

The antibiotic Raxar was approved in November 1997 despite evidence from clinical studies suggesting it could cause several fatal heart-rhythm disruptions. Click on FAQ on Arrhythmia: Raxar, to learn more about this issue.

When Raxar clinical trials came under review by the FDA, a medical officer suspected that two out of four patients who died after taking Raxar in clinical trials possibly suffered heart-rhythm disturbances caused by the drug. FDA officials, however, chose...MORE >>

---

Related Information FAQ on Arrhythmia: Raxar

Links and Resources RxList View Complete List >>

---

Featured Articles on Raxar

• June 06, 2003 - Glaxo compensates Otsuka for abandoning antibiotic
• August 15, 2001 - Undue Influence: How the drug industry's power goes unchecked and why the problem is likely to get worse
• January 15, 2001 - Beware These Drugs: They're linked to sudden death
• December 20, 2000 - Drug After Drug: Raxar warning ignored
• March 1, 2000 - Overexposed
• November 1, 1999 - Withdrawal of Product: Raxar

---

Browse Books About Drug Litigation

1.The Drug Lords : America's...

2.Deadly Drug Interactions : The People's...

3.The Pdr Family Guide to Prescription...

4.The Essential Guide to Prescription...

5.2001 Mosby's GenRx: A Comprehensive...

6.The American Pharmaceutical...

---

The above is not legal advice. That can only come from a qualified attorney who is familiar with all the facts and circumstances of a particular, specific case and the relevant law. See Terms of Use.